Market Tracker

05/26 5:16pm ET

BioDelivery Sciences International Inc (NASDAQ:BDSI)

2.40
Delayed Data
As of May 26
 +0.20 / +9.09%
Today’s Change
1.50
Today|||52-Week Range
3.10
+37.14%
Year-to-Date
2 Oversold Biopharmas With Big 2017 Upsides
May 22 / TheStreet.com - Paid Partner Content
BioDelivery (BDSI) Q1 Earnings Beat Estimates, Stock Gains
May 16 / Zacks.com - Paid Partner Content
BioDelivery Sciences International (BDSI) Jumps: Stock Up 5%
May 18 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close2.20
Today’s open2.30
Day’s range2.25 - 2.45
Volume1,105,368
Average volume (3 months)548,689
Market cap$132.8M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-73.61%
Earnings growth (this year)+106.50%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-67.77%
P/E ratioNM
Price/Sales6.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...+0.10+6.06%
SBPHSpring Bank Pharmace...-0.15-1.08%
--China Health Group I...+0.00+2.96%
CRMECardiome Pharma Corp+0.20+4.84%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$15.5M
Annual profit (last year)-$67.1M
Net profit margin-431.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Vice Chairman, President &
Chief Executive Officer
Mark A. Sirgo
CFO, Principal Accounting Officer &
Secretary
Ernest R. de Paolantonio
Corporate headquarters
Raleigh, North Carolina

Forecasts